R. Apte
Molecular Biology · 2016–2019
A researcher in the Science corpus: 2 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 35 citations into it
- Oncology — 24 citations into it
- Cancer Research — 17 citations into it
Whom R. Apte trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- N. Ferrara
- Rakesh K. Jain
- H. Gerber
- Greg T. Motz
- A. Adamis
- G. Semenza
- R. Kerbel
- G. Bergers
- Kenneth J. Hillan
- Alicia S. Chung
Papers from R. Apte's perspective
Ordered by how strongly the researchers R. Apte trusts endorse each paper. Same corpus, a different order for every researcher.
- Basic and therapeutic aspects of angiogenesis. (Cell)
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system (Nature reviews. Molecular cell biology)
- Molecular regulation of vessel maturation (Nature Medicine)
- Deciphering and reversing tumor immune suppression. (Immunity)
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
- Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. (Cancer Research)
- Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
- AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. (Cancer Cell)
- Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. (Cell)
- Lymphangiogenesis in development and human disease (Nature)
Their papers
- VEGF in Signaling and Disease: Beyond Discovery and Development (2019) — 2,318 citations
- Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice (2016) — 803 citations